Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high evels of Th1 cytokines and the IL-4 antagonist IL-4δ2

被引:145
作者
Demissie, A
Abebe, M
Aseffa, A
Rook, G
Fletcher, H
Zumla, A
Weldingh, K
Brock, I
Andersen, P
Doherty, TM
机构
[1] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark
[2] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
[3] UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London, England
[4] Univ Zambia, Sch Med, Lusaka, Zambia
关键词
D O I
10.4049/jimmunol.172.11.6938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The majority of healthy individuals exposed to Mycobacterium tuberculosis will not develop disease and identifying what constitutes "protective immunity" is one of the holy grails of M. tuberculosis immunology. It is known that IFN-gamma is essential for protection, but it is also apparent that IFN-gamma levels alone do not explain the immunity/susceptibility dichotomy. The controversy regarding correlates of immunity persists because identifying infected but healthy individuals (those who are immune) has been problematic. We have therefore used recognition of the M. tuberculosis virulence factor early secretory antigenic target 6 to identify healthy, but infected individuals from tuberculosis (TB)-endemic and nonendemic regions (Ethiopia and Denmark) and have compared signals for cytokines expressed directly ex vivo with the pattern found in TB patients. We find that TB patients are characterized by decreased levels of Th1 cytokines and increased levels of IL-10 compared with the healthy infected and noninfected community controls. Interestingly, the healthy infected subjects exhibited a selective increase of message for the IL-4 antagonist, IL-4delta2, compared with both TB patients or noninfected individuals. These data suggest that long-term control of M. tuberculosis infection is associated not just with elevated Th1 responses but also with inhibition of the Th2 response.
引用
收藏
页码:6938 / 6943
页数:6
相关论文
共 32 条
  • [1] Tuberculosis subunit vaccine development:: on the role of interferon-γ
    Agger, EM
    Andersen, P
    [J]. VACCINE, 2001, 19 (17-19) : 2298 - 2302
  • [2] Specific immune-based diagnosis of tuberculosis
    Andersen, P
    Munk, ME
    Pollock, JM
    Doherty, TM
    [J]. LANCET, 2000, 356 (9235) : 1099 - 1104
  • [3] Antagonistic effects of an alternative splice variant of human IL-4, lL-4δ2, on IL-4 activities in human monocytes and B cells
    Arinobu, Y
    Atamas, SP
    Otsuka, T
    Niiro, H
    Yamaoka, K
    Mitsuyasu, H
    Niho, Y
    Hamasaki, N
    White, B
    Izuhara, K
    [J]. CELLULAR IMMUNOLOGY, 1999, 191 (02) : 161 - 167
  • [4] Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response
    Chiaramonte, MG
    Mentink-Kane, M
    Jacobson, BA
    Cheever, AW
    Whitters, MJ
    Goad, MEP
    Wong, A
    Collins, M
    Donaldson, DD
    Grusby, MJ
    Wynn, TA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) : 687 - 701
  • [5] COLDITZ GA, 1995, PEDIATRICS, V96, P29
  • [6] DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE
    COOPER, AM
    DALTON, DK
    STEWART, TA
    GRIFFIN, JP
    RUSSELL, DG
    ORME, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2243 - 2247
  • [7] Corbett EL, 1996, BRIT J HOSP MED, V56, P200
  • [8] de Jong R, 1998, SCIENCE, V280, P1435
  • [9] T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts
    Demissie, A
    Ravn, P
    Olobo, J
    Doherty, TM
    Eguale, T
    Geletu, M
    Hailu, W
    Andersen, P
    Britton, S
    [J]. INFECTION AND IMMUNITY, 1999, 67 (11) : 5967 - 5971
  • [10] Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002